Locoregional Therapy of Hepatocellular Carcinoma

Ali Habib, Kush R Desai, Ryan Hickey, Bartley Garver Thornburg, Robert J Lewandowski, Riad Salem*

*Corresponding author for this work

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.

Original languageEnglish (US)
Pages (from-to)401-420
Number of pages20
JournalClinics in Liver Disease
Volume19
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hepatocellular Carcinoma
Therapeutics
Catheters
Transplantation
Population

Keywords

  • Hepatocellular carcinoma
  • Interventional oncology
  • Locoregional therapies
  • Percutaneous ethanol injection
  • Radioembolization
  • Radiofrequency ablation
  • Transarterial chemoembolization
  • Transplantation

ASJC Scopus subject areas

  • Hepatology

Cite this

@article{4cb3e707e4bf4b90bf478b773e2c7340,
title = "Locoregional Therapy of Hepatocellular Carcinoma",
abstract = "Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.",
keywords = "Hepatocellular carcinoma, Interventional oncology, Locoregional therapies, Percutaneous ethanol injection, Radioembolization, Radiofrequency ablation, Transarterial chemoembolization, Transplantation",
author = "Ali Habib and Desai, {Kush R} and Ryan Hickey and Thornburg, {Bartley Garver} and Lewandowski, {Robert J} and Riad Salem",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.cld.2015.01.008",
language = "English (US)",
volume = "19",
pages = "401--420",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "2",

}

Locoregional Therapy of Hepatocellular Carcinoma. / Habib, Ali; Desai, Kush R; Hickey, Ryan; Thornburg, Bartley Garver; Lewandowski, Robert J; Salem, Riad.

In: Clinics in Liver Disease, Vol. 19, No. 2, 01.01.2015, p. 401-420.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Locoregional Therapy of Hepatocellular Carcinoma

AU - Habib, Ali

AU - Desai, Kush R

AU - Hickey, Ryan

AU - Thornburg, Bartley Garver

AU - Lewandowski, Robert J

AU - Salem, Riad

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.

AB - Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discusses key data regarding the effectiveness of locoregional therapies in treating these patients. Disease-specific treatment is discussed in the context of hepatocellular carcinoma, with additional data discussed in the context of transplantation. As rapid innovation occurs in the realm of oncology, interventional oncology represents a safe, effective alternative that continues to generate impressive data that could potentially change treatment paradigms.

KW - Hepatocellular carcinoma

KW - Interventional oncology

KW - Locoregional therapies

KW - Percutaneous ethanol injection

KW - Radioembolization

KW - Radiofrequency ablation

KW - Transarterial chemoembolization

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84928829356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928829356&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2015.01.008

DO - 10.1016/j.cld.2015.01.008

M3 - Review article

C2 - 25921670

AN - SCOPUS:84928829356

VL - 19

SP - 401

EP - 420

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 2

ER -